GGrantIndex
Sort

89,613 grants matching depression

Exosome based therapeutics in Huntington's disease

$988,058
Neil Aronin · Univ Of Massachusetts Med Sch Worcester · UH3 · FY2015 · TR

Developing novel technologies to monitor nociception and opioid administration during surgery and general anesthesia in order to minimize post-operative opioid requirements

$987,966
Tuan Le Mau · Pascall Systems, Incorporated · R42 · FY2024 · DA

Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease

$986,995
Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2017 · MH

Collaborative Research: CUE-T: Hidden Curricula-Addressing Unseen Challenges within Computer Science Education

$986,954
Pedro Guillermo Feijoo Garcia · Georgia Tech Research Corporation · · FY2025 · CSE

GENETIC ANALYSIS OF BIPOLAR DISORDER

$986,935
Upstate Medical University · R01 · FY2003 · MH

Digital multidomain lifestyle intervention to address cognitive health and modifiable risk factors for Alzheimer's disease

$986,926
Jordan Glenn · Neurotrack Technologies, Inc. · R44 · FY2021 · AG

Attack Major Source of Abused Opioids: Molecularly Deactivate Unused Rx Opioids

$986,904
Thomas E Jenkins · Elysium Therapeutics, Inc. · R44 · FY2017 · DA

Biological And Biochemical Characterization Of Sigma Receptors

$986,688
Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2016 · DA

Epigenetic susceptibility of behavioral and addictive disorders during pre/pubescence after natural disaster exposures in-utero

$986,519
Yoko Nomura · Queens College · R01 · FY2023 · DA

Communication Bridge: A person-centered Internet-based intervention for individuals with primary progressive aphasia

$986,375
Emily J Rogalski · Northwestern University At Chicago · R01 · FY2020 · AG

GENETIC ANALYSIS OF BIPOLAR DISORDER

$986,321
Upstate Medical University · R01 · FY2002 · MH

LATINO RESEARCH PROGRAM PROJECT

$986,127
Cambridge Health Alliance · P01 · FY2002 · MH

Efficacy of CBT for Adherence and Depression in HIV Care Settings

$986,019
Steven A Safren · Massachusetts General Hospital · R01 · FY2009 · MH

CAREER: Identifying Aspects of Research that Exacerbate Undergraduate and Graduate Student Depression and Developing Interventions to Improve Student Mental Health

$985,868
Katelyn M Cooper · Arizona State University · · FY2022 · EDU

Advanced Center for Latino and MH Systems Research

$985,750
Margarita Alegria · Cambridge Health Alliance · P50 · FY2006 · MH

Attack Major Source of Abused Opioids: Molecularly Deactivate Unused Rx Opioids

$985,349
Thomas E Jenkins · Elysium Therapeutics, Inc. · R44 · FY2018 · DA

Longitudinal Assessment of Brain Structure and Function in Myotonic Dystrophy

$985,342
Peggy C Nopoulos · University Of Iowa · R01 · FY2019 · NS

Dissemination of MAPseq and BARseq for High-Throughput Brain Mapping

$985,210
Anthony M Zador · Cold Spring Harbor Laboratory · U24 · FY2023 · NS

Developing Infrastructure for Patient-Centered Outcomes Research at Denver Health

$984,573
Edward Havranek · Denver Health And Hospital Authority · R24 · FY2013 · HS

Control Of G Protein Signaling: Role Of The RGSs

$984,558
John H Kehrl · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease

$984,151
Stephen R Salton · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG

Enhancing Clinical Meaningfulness And Usefulness Of PROMIS Pediatric Measures Via Validation In Children And Adolescents With Rheumatic Disease, Cancer, Or Inflammatory Bowel Disease

$983,988
Bryce B Reeve · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AR

Telephone Versus Face-to-Face Administration of CBT for Depression

$983,850
David Curtis Mohr · Northwestern University At Chicago · R01 · FY2008 · MH

Olera - Online Platform to Increase Access to Personalized Educational and Professional Assistance for AD/ADRD Caregivers

$983,732
Tokunbo Falohun · Olera Inc. · R44 · FY2022 · AG

Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergics

$983,554
Shelly L Gray · Kaiser Foundation Research Institute · U19 · FY2024 · AG